Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • AMPK–SQSTM1 Feedback Under Metabolic Stress

    2026-09-28

    AMPK–SQSTM1 Feedback Under Metabolic Stress

    Study Background and Research Question

    Metabolic stress in tumors is not simply a shortage of nutrients. Glucose limitation can reduce NADPH-generating flux, increase reactive oxygen species (ROS), and impair mitochondrial ATP production. The resulting energy and oxidative pressures reinforce one another, creating a selective environment in which cancer cells must continuously adjust metabolism, lysosomal activity, and antioxidant defenses.

    The STK11/LKB1–AMPK pathway is a central response to this environment. AMPK can preserve energy balance by limiting ATP-consuming processes while supporting pathways that maintain ATP and NADPH. A separate but complementary defense system is controlled by NFE2L2/NRF2, whose activity induces antioxidant and cytoprotective genes. The reference study, Metabolic stress induces a double-positive feedback loop between AMPK and SQSTM1/p62 conferring dual activation of AMPK and NFE2L2/NRF2 to synergize antioxidant defense, asked how these pathways communicate during metabolic stress.

    The question is particularly relevant to non-small cell lung cancer (NSCLC) carrying alterations in STK11/LKB1 and KEAP1. The authors sought to determine whether loss of one stress-adaptation route creates pressure for activation of the other, and whether SQSTM1/p62 serves as the molecular connection. The study and its mechanistic conclusions are described in the reference publication in Autophagy.

    Key Innovation from the Reference Study

    The main innovation is the identification of a reciprocal, rather than one-directional, relationship between AMPK and SQSTM1/p62. Under metabolic stress, SQSTM1 was induced and phosphorylated. In turn, SQSTM1 promoted two coordinated outputs: autophagic removal of KEAP1, which released NFE2L2/NRF2 activity, and formation of an AXIN–STK11–AMPK complex on the lysosomal membrane, which supported AMPK activation.

    The feedback was double-positive because AMPK activity was also required for the stress-induced increase and phosphorylation of SQSTM1. Thus, AMPK and p62 can reinforce each other instead of operating as isolated stress sensors. This model adds an important layer to conventional descriptions of AMPK or NRF2 signaling: the lysosome is presented as a signaling platform where energy sensing, autophagy, transcriptional regulation, and ion-dependent stress responses converge.

    Mechanistically, the study links low-glucose metabolism to lysosomal deacidification. Reduced lysosomal acidity and AMPK-dependent proton reduction were associated with PPP2/PP2A-dependent dephosphorylation of TFEB and TFE3, transcription factors that increased SQSTM1 expression. In parallel, ROS and pH-dependent lysosomal calcium release activated MAP3K7/TAK1, increasing SQSTM1 phosphorylation. The reported importance of SQSTM1 phosphorylation at S24 and S226 further distinguishes this mechanism from a nonspecific increase in p62 abundance.

    Methods and Experimental Design Insights

    The experimental design combined metabolic perturbation with molecular dissection of lysosomal and antioxidant pathways. Low-nutrient or low-glucose conditions were used to model metabolic stress, while changes in SQSTM1 abundance and phosphorylation, AMPK activation, NRF2 signaling, KEAP1 turnover, and antioxidant adaptation were evaluated. The study also examined how restoring extracellular protons with lactic acid altered the response, providing a physiologically relevant test of whether acidity modifies the stress circuit.

    Several classes of perturbation strengthened the causal analysis. Autophagy and lysosomal acidification were probed with agents such as bafilomycin A1 and concanamycin A; ROS involvement was examined using antioxidant intervention; and protein interactions were assessed through immunoprecipitation and lysosome-associated signaling analyses. The reported use of TFEB/TFE3, AXIN, STK11, SQSTM1, and phosphosite-focused experiments helped separate transcriptional induction, lysosomal complex assembly, and post-translational regulation.

    A useful feature of the design is its pathway triangulation. KEAP1 degradation provided a mechanistic bridge to NRF2 activation, whereas AXIN–STK11 complex formation addressed AMPK activation at the lysosomal surface. Perturbation of lysosomal proton and calcium handling then connected organelle physiology to TAK1-dependent SQSTM1 phosphorylation. This arrangement reduces the likelihood that the findings reflect only a generic response to cell stress.

    Protocol Parameters

    • Metabolic-stress comparison: Compare nutrient-replete and low-nutrient or low-glucose conditions while measuring both AMPK activity and SQSTM1 expression or phosphorylation in the same experiment.
    • Lysosomal mechanism: Use lysosomal acidification perturbation as a mechanistic control, and interpret changes in KEAP1, NRF2, AXIN, and AMPK together rather than as independent endpoints.
    • ROS and calcium branch: Include antioxidant intervention and analysis of lysosomal calcium-dependent TAK1 signaling when testing whether oxidative stress drives SQSTM1 phosphorylation.
    • Proton-rescue condition: Test whether lactic-acid-associated proton availability reverses the metabolic-stress phenotype before assigning the response solely to glucose depletion.
    • Phosphosite validation: Treat SQSTM1 S24 and S226 as mechanistic sites requiring direct validation, not merely as markers of increased total p62.

    These points summarize the logic of the reference study and provide a framework for replication. They should not be interpreted as a substitute for the detailed concentrations, exposure times, cell models, and controls in the full article.

    Core Findings and Why They Matter

    First, metabolic stress increased both SQSTM1 expression and phosphorylation. This response was functionally important because SQSTM1 enabled dual activation of NRF2 and AMPK. Through autophagic KEAP1 degradation, p62 favored accumulation and activity of NRF2. Through AXIN–STK11–AMPK complex formation at lysosomes, it supported energy-stress signaling.

    Second, AMPK was necessary for the induction and phosphorylation of SQSTM1. This reciprocal requirement defines the double-positive feedback loop. It also provides a plausible explanation for sustained pathway activation during prolonged nutrient and oxidative pressure: once the circuit is engaged, AMPK and p62 can stabilize the cellular state that supports antioxidant defense.

    Third, the study assigns distinct roles to lysosomal transcriptional and ion-signaling events. Deacidification-associated PP2A activity affected TFEB and TFE3, increasing SQSTM1 expression. ROS and pH-dependent calcium release activated TAK1, increasing SQSTM1 phosphorylation. The findings therefore connect lysosomal acidity, calcium signaling, transcription-factor regulation, and protein modification within one stress-adaptation model.

    Finally, lactic acid-associated proton supply abrogated the effects induced by metabolic stress. This observation matters for tumor biology because the tumor microenvironment can contain both nutrient limitation and extracellular acidification. It suggests that the response to glucose restriction depends on the chemical context surrounding the cell, not only on intracellular glucose availability.

    Collectively, the results offer a mechanistic explanation for why STK11 and KEAP1 alterations may co-occur in NSCLC. When STK11–AMPK signaling is weakened, constitutive NRF2 activity caused by KEAP1 disruption may compensate for the loss of antioxidant and metabolic adaptation. Conversely, p62-dependent coupling of the two pathways may help tumor cells tolerate stress even when one branch is genetically impaired. The study supports therapeutic hypotheses, but the evidence is most mature as a mechanistic framework rather than as a validated treatment strategy.

    Why this cross-domain matters, maturity, and limitations

    The reference paper is centered on cancer-cell metabolism, autophagy, and antioxidant defense; it does not test TRPV1 biology or sensory neurons. A TRPV1 antagonist therefore should not be treated as a direct probe of the AMPK–SQSTM1 circuit. The cross-domain value is methodological: researchers studying sensory stress responses can use the paper's separation of metabolic, lysosomal, calcium, and ROS signals to design cleaner experiments.

    For example, in sensory neuron signaling studies, capsaicin-evoked calcium entry and peptide secretion can be measured separately from responses caused by nutrient stress or altered extracellular pH. An inhibition of capsaicin-induced calcium influx experiment can establish receptor-proximal activity, while a CGRP release inhibition assay can test whether reduced neuropeptide output follows from reduced TRPV1 signaling or from broader cellular injury. These assays may inform pain mechanism research, but they do not demonstrate that TRPV1 controls the AMPK–SQSTM1–NRF2 feedback loop described in the reference paper.

    The maturity of this bridge is therefore practical rather than evidentiary. It supports experimental separation of pathways, not a new claim about shared molecular causality. Appropriate controls should include vehicle treatment, metabolic-stress-only conditions, viability measurements, and independent confirmation of AMPK, SQSTM1, NRF2, and lysosomal responses.

    Comparison with Existing Internal Articles

    The internal article AMPK–SQSTM1 Feedback in Metabolic Stress provides a concise interpretation of the same central finding: AMPK and SQSTM1/p62 reinforce one another while coordinating KEAP1 degradation, NRF2 activation, and lysosomal signaling. The reference paper extends that framework by identifying the roles of lysosomal deacidification, TFEB/TFE3 dephosphorylation, TAK1 activation, and SQSTM1 phosphorylation sites.

    A second internal resource, AMG 9810: Decoding Calcium Signals Under Stress, approaches the problem from a sensory-assay perspective. Its relevance is limited but useful: it emphasizes separating receptor-driven calcium and CGRP responses from broader metabolic-stress signals. Together, the two resources suggest a disciplined workflow in which the Autophagy paper supplies the metabolic-stress logic, while sensory assays test receptor-specific calcium and secretory outputs without claiming that both systems share an established mechanism.

    Limitations and Transferability

    The study has several boundaries. The mechanistic model is most directly relevant to metabolically stressed cancer cells and may not transfer quantitatively to normal tissues, immune cells, or sensory neurons. The abstract supports a strong relationship among AMPK, SQSTM1, NRF2, KEAP1, lysosomal pH, ROS, and calcium, but pathway dependence can vary with genotype, nutrient composition, cell lineage, and baseline lysosomal function.

    Another limitation is that feedback-loop language can obscure temporal order. Increased AMPK activity, p62 expression, KEAP1 degradation, and NRF2 activation may occur at overlapping times, so causal interpretation requires perturbations that distinguish initiation from maintenance. Likewise, pharmacological manipulation of autophagy, ROS, or lysosomal acidification can produce off-target effects. Genetic rescue, phosphosite mutants, and orthogonal measurements remain important for validating the proposed circuit.

    The lactic-acid result also cautions against modeling nutrient stress with glucose concentration alone. Extracellular pH, proton gradients, lactate metabolism, and lysosomal acidification should be recorded or controlled when comparing experimental systems. These limitations do not negate the paper's contribution; they define where the model is strongest and where further validation is needed.

    Research Support Resources

    For sensory-neuron workflows that require pharmacological separation of TRPV1-dependent signals from metabolic-stress effects, researchers can use AMG 9810 (SKU B7018), a selective competitive TRPV1 antagonist. The product information reports nanomolar activity at human and rat TRPV1 and suitability for blocking capsaicin-evoked calcium influx and CGRP release; researchers should optimize concentration, solvent controls, exposure time, and cell-specific tolerability in their own assay.